These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 16724011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
    Schelleman H, Klungel OH, van Duijn CM, Witteman JC, Hofman A, de Boer A, Stricker BH.
    Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
    [Abstract] [Full Text] [Related]

  • 4. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
    Schelleman H, Klungel OH, Witteman JC, Breteler MM, Yazdanpanah M, Danser AH, Hofman A, van Duijn CM, de Boer A, Stricker BH.
    Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437
    [Abstract] [Full Text] [Related]

  • 5. Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis.
    Schelleman H, Klungel OH, Witteman JC, Hofman A, van Duijn CM, de Boer A, Stricker BH.
    Br J Clin Pharmacol; 2007 Jul; 64(1):57-66. PubMed ID: 17298481
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 Jul; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.
    Marin P, Julve R, Chaves FJ, Giner V, Pascual JM, Armengod ME, Redon J.
    J Hum Hypertens; 2004 Jan; 18(1):25-31. PubMed ID: 14688807
    [Abstract] [Full Text] [Related]

  • 9. T1198C polymorphism of the angiotensinogen gene and antihypertensive response to angiotensin-converting enzyme inhibitors.
    Yu H, Lin S, Liu G, Zhang Y, Deng C, Ma W.
    Hypertens Res; 2005 Dec; 28(12):981-6. PubMed ID: 16671337
    [Abstract] [Full Text] [Related]

  • 10. Response of blood pressure to maximum exercise in hypertensive patients under different therapeutic programs.
    de Queiroz Carreira MA, Ribeiro JC, Caldas JA, Tavares LR, Nani E.
    Arq Bras Cardiol; 2000 Oct; 75(4):281-8. PubMed ID: 11058925
    [Abstract] [Full Text] [Related]

  • 11. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
    Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, Knol MJ, de Boer A, Grobbee DE, Geerlings MI, Heerdink ER, Klungel OH.
    J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
    [Abstract] [Full Text] [Related]

  • 12. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database.
    Hashimoto S, Urushihara H, Hinotsu S, Kosugi S, Kawakami K.
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
    Liou YS, Ma T, Tien L, Lin CM, Jong GP.
    Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
    [Abstract] [Full Text] [Related]

  • 15. [Stress-associated hypertension in the work place: results of the STARLET project].
    Lüders S, Hammersen F, Kulschewski A, Frerichs A, Frieg R, Hahnheiser D, Reich G, Schnieders M, Schrandt G, Schrader J.
    Dtsch Med Wochenschr; 2006 Nov 17; 131(46):2580-5. PubMed ID: 17096303
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Both angiotensinogen M235T and alpha-adducin G460W polymorphisms are associated with hypertension in the Japanese population.
    Nakamura Y, Tabara Y, Miki T, Tamaki S, Kita Y, Okamura T, Ueshima H.
    J Hum Hypertens; 2007 Mar 17; 21(3):253-5. PubMed ID: 17215849
    [No Abstract] [Full Text] [Related]

  • 18. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Clin Ther; 2007 Feb 17; 29(2):305-15. PubMed ID: 17472822
    [Abstract] [Full Text] [Related]

  • 19. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE, Mohiuddin SM, Lucas BD, Stading JA, Stoysich AM, Ryschon K.
    Clin Ther; 1994 Feb 17; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [Abstract] [Full Text] [Related]

  • 20. The alpha-adducin Gly460Trp polymorphism and the antihypertensive effects of exercise among men with high blood pressure.
    Pescatello LS, Blanchard BE, Tsongalis GJ, Maresh CM, O'Connell A, Thompson PD.
    Clin Sci (Lond); 2007 Sep 17; 113(5):251-8. PubMed ID: 17472579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.